Co-Authors
This is a "connection" page, showing publications co-authored by Laura Holman and Kai Ding.
Connection Strength
0.281
-
Improving cancer care for American Indians with cervical cancer in the Indian Health Service (IHS) system - Navigation may not be enough. Gynecol Oncol. 2018 04; 149(1):89-92.
Score: 0.142
-
Feasibility IB trial of paclitaxel/carboplatin + Galunisertib. (a small molecule inhibitor of the kinase domain of type 1 TGF-B receptor) in patients with newly diagnosed, persistent or recurrent carcinosarcoma of the uterus or ovary. Gynecol Oncol. 2025 Dec; 203:158-164.
Score: 0.060
-
A phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium. Gynecol Oncol. 2022 07; 166(1):44-49.
Score: 0.047
-
Primary and acquired platinum-resistance among women with high grade serous ovarian cancer. Gynecol Oncol. 2016 08; 142(2):225-30.
Score: 0.031